A novel conditional active biologic anti-EpCAM x anti-CD3 bispecific antibody with synergistic tumor selectivity for cancer immunotherapy

一种新型条件性活性生物制剂抗EpCAM x 抗CD3双特异性抗体，具有协同肿瘤选择性，可用于癌症免疫治疗。